Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions

Fig. 2

Methylation levels of cg13096260 and cg12993163. Difference analysis of cg13096260 (a) and cg12993163 (b) in TCGA CRC methylation database. Differential methylation levels of cg13096260 (c) and cg12993163 (d) in cancerous and normal precancerous tissues of patients with CRC. Methylation levels of cg13096260 (e) and cg12993163 (f) in stool samples of patients with NED, AA, stage I and II CRC, and stage III&IV CRC. Methylation levels of cg13096260 (g) and cg12993163 (h) in blood samples of patients with NED, AA, stage I and II CRC, and stage III&IV CRC. NED no evidence of disease, AA advanced adenoma, CRC colorectal cancer

Back to article page